Abstract: With the advancement of treating methods, the survival rate and survival time of tumor patients have improved significantly, but the cancer therapeutics-related cardiac dysfunction seriously threatens the health of tumor survivors, among which the cardiotoxicity caused by anthracyclines (ANTs) is extremely common and can lead to irreversible heart damage. Early detection and timely treatment of cardiotoxicity caused by ANTs are essential for the recovery of cardiac function, so early detection of cardiotoxicity is of great clinical importance. The author focuses on new imaging methods that may help to detect the cardiotoxicity caused by ANTs early, including myocardial strain imaging by echocardiography, myocardial strain imaging and quantification imaging of myocardial tissue by cardiac magnetic resonance and PET/CT imaging, in order to provide valuable information for early clinical detection of cardiotoxicity caused by ANTs.